Clinical and epidemiological characteristics of multiple sclerosis patients receiving disease-modifying treatment in Poland.

CONCLUSIONS: In Poland there is a need to increase MS patient access to DMTs by improving the organisation of drug programmes.
PMID: 32219813 [PubMed - as supplied by publisher]

Source: Neurologia i Neurochirurgia Polska - March 26, 2020 Category: Neurology Authors: Kapica-Topczewska K, Collin F, Tarasiuk J, Chorąży M, Czarnowska A, Kwaśniewski M, Brola W, Bartosik-Psujek H, Adamczyk-Sowa M, Kochanowicz J, Kułakowska A Tags: Neurol Neurochir Pol Source Type: research